Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent

被引:20
|
作者
Turco, Simona [1 ]
Tardy, Isabelle [2 ]
Frinking, Peter [2 ]
Wijkstra, Hessel [3 ]
Mischi, Massimo [1 ]
机构
[1] Eindhoven Univ Technol, Dept Elect Engn, Groene Loper 19, NL-5600 MB Eindhoven, Netherlands
[2] BRACCO SUISSE SA, Route Galaise 31, CH-1228 Geneva, Switzerland
[3] Acad Med Ctr, Dept Urol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源
PHYSICS IN MEDICINE AND BIOLOGY | 2017年 / 62卷 / 06期
基金
欧洲研究理事会;
关键词
molecular imaging; contrast-enhanced ultrasound; angiogenesis; targeted microbubbles; pharmacokinetic modeling; ACOUSTIC RADIATION FORCE; ANTIANGIOGENIC THERAPY; TUMOR ANGIOGENESIS; FUTURE-DIRECTIONS; PROSTATE-CANCER; MICROBUBBLES; DISPERSION; BR55; LOCALIZATION; GROWTH;
D O I
10.1088/1361-6560/aa5e9a
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Ultrasound molecular imaging (USMI) is an emerging technique to monitor diseases at the molecular level by the use of novel targeted ultrasound contrast agents (tUCA). These consist of microbubbles functionalized with targeting ligands with high-affinity for molecular markers of specific disease processes, such as cancer-related angiogenesis. Among the molecular markers of angiogenesis, the vascular endothelial growth factor receptor 2 (VEGFR2) is recognized to play a major role. In response, the clinical-grade tUCA BR55 was recently developed, consisting of VEGFR2-targeting microbubbles which can flow through the entire circulation and accumulate where VEGFR2 is over-expressed, thus causing selective enhancement in areas of active angiogenesis. Discrimination between bound and free microbubbles is crucial to assess cancer angiogenesis. Currently, this is done non-quantitatively by looking at the late enhancement, about 10 min after injection, or by calculation of the differential targeted enhancement, requiring the application of a high-pressure ultrasound (US) burst to destroy all the microbubbles in the acoustic field and isolate the signal coming only from bound microbubbles. In this work, we propose a novel method based on mathematical modeling of the binding kinetics during the tUCA first pass, thus reducing the acquisition time and with no need for a destructive US burst. Fitting time-intensity curves measured with USMI by the proposed model enables the assessment of cancer angiogenesis at both the vascular and molecular levels. This is achieved by estimation of quantitative parameters related to the microvascular architecture and microbubble binding. The proposed method was tested in 11 prostate-tumor bearing rats by performing USMI after injection of BR55, and showed good agreement with current USMI methods. The novel information provided by the proposed method, possibly combined with the current non-quantitative methods, may bring deeper insight into cancer angiogenesis, and thus potentially improve cancer diagnosis and management.
引用
收藏
页码:2449 / 2464
页数:16
相关论文
共 50 条
  • [21] Evaluation of a targeted nanobubble ultrasound contrast agent for potential tumor imaging
    Li Chunfang
    Shen Chunxu
    Liu Haijuan
    Wu Kaizhi
    Zhou Qibing
    Ding Mingyue
    MEDICAL IMAGING 2015: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL, AND FUNCTIONAL IMAGING, 2015, 9417
  • [22] Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy
    Departments of Biomedical Engineering, University of Alabama at Birmingham, G082 Volker Hall, 1670 University Blvd, Birmingham, AL 35294-0019, United States
    不详
    不详
    J. Ultrasound Med., 2012, 10 (1543-1550):
  • [23] Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging
    Klibanov, Alexander L.
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2009, 47 (08) : 875 - 882
  • [24] Molecular Ultrasound Imaging Using a Targeted Contrast Agent for Assessing Early Tumor Response to Antiangiogenic Therapy
    Sorace, Anna G.
    Saini, Reshu
    Mahoney, Marshall
    Hoyt, Kenneth
    JOURNAL OF ULTRASOUND IN MEDICINE, 2012, 31 (10) : 1543 - 1550
  • [25] Molecular imaging with targeted contrast agents and high frequency ultrasound
    van Wamel, Annemieke
    Celebi, Muzaffer
    Hossack, John A.
    Backer, Joseph M.
    Backer, Marina V.
    Ley, Klaus
    de Jong, Nico
    Klibanov, Alexander L.
    2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 961 - +
  • [26] Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging
    Alexander L. Klibanov
    Medical & Biological Engineering & Computing, 2009, 47 : 875 - 882
  • [27] Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
    Yang, Feng
    Chen, Zhi-Yi
    Lin, Yan
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (08) : 1516 - 1527
  • [28] A stimulus-responsive contrast agent for ultrasound molecular imaging
    Borden, Mark A.
    Zhang, Hua
    Gillies, Robert J.
    Dayton, Paul A.
    Ferrara, Katherine W.
    BIOMATERIALS, 2008, 29 (05) : 597 - 606
  • [29] Angiogenesis Imaging by Spatiotemporal Analysis of Ultrasound Contrast Agent Dispersion Kinetics
    Mischi, Massimo
    Kuenen, Maarten P. J.
    Wijkstra, Hessel
    IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL, 2012, 59 (04) : 621 - 629
  • [30] Development of Antibody-carrying Microbubbles Based on Clinically Available Ultrasound Contrast Agent for Targeted Molecular Imaging
    Otani, Kentaro
    Yamahara, Kenichi
    CIRCULATION, 2009, 120 (18) : S328 - S328